• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Safety and Pharmacokinetics Of Clofarabine In Combination With High-Dose Cytarabine and Liposomal Daunorubicin In Pediatric AML: Results Of a Phase 1 Combination Study By The ITCC Consortium 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • Safety and Pharmacokinetics Of Clofarabine In Combination With High-Dose Cytarabine and Liposomal Daunorubicin In Pediatric AML: Results Of a Phase 1 Combination Study By The ITCC Consortium
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • Safety and Pharmacokinetics Of Clofarabine In Combination With High-Dose Cytarabine and Liposomal Daunorubicin In Pediatric AML: Results Of a Phase 1 Combination Study By The ITCC Consortium
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Safety and Pharmacokinetics Of Clofarabine In Combination With High-Dose Cytarabine and Liposomal Daunorubicin In Pediatric AML: Results Of a Phase 1 Combination Study By The ITCC Consortium

    View/Open
    Accepted version (32.5Kb)
    Volume
    122
    Issue
    21
    ISSN
    0006-4971
    Metadata
    Show full item record
    Authors
    Zwaan, CM; Dworzak, M; Klingebiel, T; Rossig, C; Leverger, G; Stary, J; De Bont, ES; Ramnarain, S; Bertrand, Y; Ghazaly, EA
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/7699
    Collections
    • Centre for Haemato-Oncology [167]
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.